Back
Seres Therapeutics, Inc. 10K Form
Sell
21
MCRB
Seres Therapeutics, Inc.
Last Price:
$16.49
Seasonality Move:
-18.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MCRB News And Ratings
See the #1 stock for the next 7 days that we like better than MCRB
MCRB Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $2.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.99 |
| Price / Book: | 3.39 |
Profitability
| EPS (TTM): | 0.60710 |
|---|---|
| Net Income (TTM): | $5.4M |
| Gross Margin: | $-14.7M |
| Return on Equity: | 16.36% |
| Return on Assets: | 3.5% |
Seres Therapeutics, Inc. Earnings Forecast
Key Seres Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 5 years.
Seres Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MCRB |
| CUSIP: | 81750R |
| Website: | serestherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 1.95 |
|---|---|
| Current Ratio: | 2.3 |
| Quick Ratio: | 2.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MCRB Technical Analysis vs Fundamental Analysis
Sell
21
Seres Therapeutics, Inc. (MCRB)
is a Sell
Is Seres Therapeutics, Inc. a Buy or a Sell?
-
Seres Therapeutics, Inc. stock is rated a SellThe current Seres Therapeutics, Inc. [MCRB] share price is $16.94. The Score for MCRB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.